ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

An Optimized Integrative Model Using Urinary Chemokines for Noninvasive Diagnosis of Acute Allograft Rejection

C. Tinel1, A. Devresse1, A. Vermorel1, D. Marx2, S. Caillard2, C. Legendre1, M. Rabant3, D. Anglicheau1

1Nephrology and Kidney Transplantation, Inserm U1151, Necker Hospital, Paris, France, 2Nephrology and Kidney Transplantation, Strasbourg University Hospital, Strasbourg, France, 3Pathology, Necker Hospital, Paris, France

Meeting: 2020 American Transplant Congress

Abstract number: 90

Keywords: Kidney transplantation, Multivariate analysis, Non-invasive diagnosis, Polyma virus

Session Information

Date: Saturday, May 30, 2020

Session Name: Biomarkers, Immune Assessment and Clinical Outcomes I

Session Time: 3:15pm-4:45pm

 Presentation Time: 3:27pm-3:39pm

Location: Virtual

Related Abstracts
  • Urinary CXCL10 Independently Improves the Noninvasive Diagnosis of Antibody-Mediated Kidney Allograft Rejection
  • Diagnostic Value and Confounding Factors of Urinary Biomarkers in the Non-Invasive Screening of Renal Allograft Inflammation

*Purpose: The aim of this study was to optimize the performance of urinary chemokines C-X-C motif ligand (CXCL) 9 and CXCL10 as noninvasive diagnostic markers of acute rejection (AR) in kidney transplant recipients (KTRs).

*Methods: CXCL9 and CXCL10 were quantified in 391 urine samples concomitant with graft biopsy, urinalysis and blood BK virus (BKV) viral load assessment. Confounding factors for chemokine elevations were identified and integrated to build a multiparametric noninvasive model of AR diagnosis.

*Results: Both urinary tract infection (UTI) and BKV reactivation were associated with increases in CXCL9 and CXCL10 levels. Compared to nonviremic patients, BKV-viremic KTRs had similarly increased levels of CXCL9 and CXCL10 in both the absence (P<0.001 and P<0.0001, respectively) and presence (P<0.01 and P<0.0001) of BKV-associated nephropathy (BKVAN). Next we built several multivariate regression models for the diagnosis of AR. Panel A illustrates the incremental performances of various biomarkers used alone or in combinations. An optimized 8-parameter model (including recipient age and sex, estimated glomerular filtration rate, donor-specific antibodies, UTI, BKV blood viral load, and urinary CXCL9 and CXCL10) diagnosed AR with high accuracy (area under the curve [AUC]=0.85, 95% confidence interval [95% CI] 0.80-0.89; P<0.0001) in an unselected cohort (Panel B-C). These 8 parameters diagnosed AR with an AUC of 0.92 (P<0.0001) in an external validation cohort. This model remained highly accurate in cases of stable graft function (AUC=0.80) or at the time of graft dysfunction (AUC=0.85) and within the first year (AUC=0.86) or later (AUC=0.90). A model threshold optimizing sensitivity (Panel D-E) gives a NPV of 0.99, while optimizing specificity gives a PPV of 0.88. The optimal threshold for clinic of -2 avoids 157 unnecessary biopsies while missing 10% of AR.

*Conclusions: Considering confounding factors rather than excluding them, we optimized a multiparametric diagnostic model for AR of kidney allografts, which achieves unprecedented accuracy for a noninvasive diagnostic tool.

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Tinel C, Devresse A, Vermorel A, Marx D, Caillard S, Legendre C, Rabant M, Anglicheau D. An Optimized Integrative Model Using Urinary Chemokines for Noninvasive Diagnosis of Acute Allograft Rejection [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/an-optimized-integrative-model-using-urinary-chemokines-for-noninvasive-diagnosis-of-acute-allograft-rejection/. Accessed March 8, 2021.

« Back to 2020 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.